Last reviewed · How we verify

recombinant factor XIII — Competitive Intelligence Brief

recombinant factor XIII (recombinant factor XIII) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline.

marketed Small molecule Live · refreshed every 30 min

Target snapshot

recombinant factor XIII (recombinant factor XIII) — Novo Nordisk A/S.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
recombinant factor XIII TARGET recombinant factor XIII Novo Nordisk A/S marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). recombinant factor XIII — Competitive Intelligence Brief. https://druglandscape.com/ci/recombinant-factor-xiii. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: